Literature DB >> 7636282

Scedosporium prolificans, a multi-resistant fungus, from a U.K. AIDS patient.

V Hopwood1, E G Evans, J Matthews, D W Denning.   

Abstract

We report the first isolation of Scedosporium prolificans (inflatum) in the U.K. The patient, with advanced AIDS and neutropenia, had respiratory tract colonisation over many months without invasive disease despite neutropenia, while on itraconazole therapy. The organism was resistant in vitro to all licensed systemic antifungal agents tested.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7636282     DOI： 10.1016/s0163-4453(95)80011-5

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


  11 in total

1.  In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates.

Authors:  Joseph Meletiadis; Jacques F G M Meis; Johan W Mouton; Juan Luis Rodriquez-Tudela; J Peter Donnelly; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Disseminated infection caused by Scedosporium prolificans in a patient with acute multilineal leukemia.

Authors:  J de Batlle; M Motjé; R Balanzà; R Guardia; R Ortiz
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

3.  Cerebral scedosporiosis: an emerging fungal infection in severe neutropenic patients: CT features and CT pathologic correlation.

Authors:  Enrique Marco de Lucas; Pablo Sádaba; Pedro Lastra García-Barón; María Luisa Ruiz Delgado; Jorge Cuevas; Ricardo Salesa; Arancha Bermúdez; Andrés González Mandly; Agustín Gutiérrez; Fidel Fernández; Fernando Marco de Lucas; Consuelo Díez
Journal:  Eur Radiol       Date:  2005-08-20       Impact factor: 5.315

4.  Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.

Authors:  Michaela Lackner; G Sybren de Hoog; Paul E Verweij; Mohammad J Najafzadeh; Ilse Curfs-Breuker; Corné H Klaassen; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

Review 5.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

6.  In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens.

Authors:  S A Radford; E M Johnson; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

7.  Antifungal activities of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans.

Authors:  M Simitsopoulou; C Gil-Lamaignere; N Avramidis; A Maloukou; S Lekkas; E Havlova; L Kourounaki; D Loebenberg; E Roilides
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 8.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

9.  [Foot injury as a rare cause of scendosporiosis with fetal outcome].

Authors:  P H Pennekamp; O Diedrich; H Zhou; C N Kraft
Journal:  Unfallchirurg       Date:  2003-10       Impact factor: 1.000

10.  Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.

Authors:  Cristina Gil-Lamaignere; Emmanuel Roilides; Juan Mosquera; Avgi Maloukou; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.